ATE543834T1 - Mit pancreaskrebs assoziierte genfamilie (lbfl313) - Google Patents

Mit pancreaskrebs assoziierte genfamilie (lbfl313)

Info

Publication number
ATE543834T1
ATE543834T1 AT07746891T AT07746891T ATE543834T1 AT E543834 T1 ATE543834 T1 AT E543834T1 AT 07746891 T AT07746891 T AT 07746891T AT 07746891 T AT07746891 T AT 07746891T AT E543834 T1 ATE543834 T1 AT E543834T1
Authority
AT
Austria
Prior art keywords
gene family
pancreasic
lbfl313
cancer
family associated
Prior art date
Application number
AT07746891T
Other languages
English (en)
Inventor
Sang-Seok Koh
Si-Young Song
Sun-A Kim
Yang-Soon Lee
Sun-Bok Jeon
Eui-Chul Park
Young-Gun Kim
Original Assignee
Lg Life Sciences Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lg Life Sciences Ltd filed Critical Lg Life Sciences Ltd
Application granted granted Critical
Publication of ATE543834T1 publication Critical patent/ATE543834T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/10—Processes for the isolation, preparation or purification of DNA or RNA
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/82—Translation products from oncogenes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Medicinal Chemistry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • General Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Plant Pathology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Physics & Mathematics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Oncology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
AT07746891T 2006-06-14 2007-06-13 Mit pancreaskrebs assoziierte genfamilie (lbfl313) ATE543834T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020060053629A KR100954322B1 (ko) 2006-06-14 2006-06-14 췌장암과 관련된 신규한 ｌｂｆｌ313 유전자
PCT/KR2007/002848 WO2007145466A1 (en) 2006-06-14 2007-06-13 Gene family (lbfl313) associated with pancreatic cancer

Publications (1)

Publication Number Publication Date
ATE543834T1 true ATE543834T1 (de) 2012-02-15

Family

ID=38831937

Family Applications (1)

Application Number Title Priority Date Filing Date
AT07746891T ATE543834T1 (de) 2006-06-14 2007-06-13 Mit pancreaskrebs assoziierte genfamilie (lbfl313)

Country Status (17)

Country Link
US (2) US20090188000A1 (de)
EP (1) EP2024500B1 (de)
JP (1) JP5388844B2 (de)
KR (1) KR100954322B1 (de)
CN (1) CN101495634B (de)
AT (1) ATE543834T1 (de)
AU (1) AU2007259576A1 (de)
BR (1) BRPI0712830A2 (de)
CA (1) CA2655213A1 (de)
ES (1) ES2381766T3 (de)
MX (1) MX2008016146A (de)
MY (1) MY150691A (de)
NO (1) NO20090174L (de)
NZ (1) NZ573102A (de)
RU (1) RU2432399C2 (de)
WO (1) WO2007145466A1 (de)
ZA (1) ZA200900224B (de)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20100034720A (ko) * 2008-09-23 2010-04-01 한국생명공학연구원 피에이유에프(ｐａｕｆ) 특이적인 인간 단일클론항체, 이를 포함하는 암 치료용 조성물, 이를 이용하는 암의 진단방법
KR101373103B1 (ko) 2011-03-28 2014-03-11 연세대학교 산학협력단 Ｐａｕｆ 및 그의 결합 파트너의 상호작용을 이용한 암 치료제의 스크리닝 방법
US10330682B2 (en) 2013-10-31 2019-06-25 Sk Telecom Co., Ltd. Composition for diagnosing pancreatic cancer and method for diagnosing pancreatic cancer using same
KR101743747B1 (ko) 2014-03-31 2017-06-07 연세대학교 산학협력단 Pauf 억제제를 유효성분으로 포함하는 항암제에 대한 화학감작용 약제학적 조성물
KR102092225B1 (ko) * 2014-04-30 2020-03-23 주식회사 엘지화학 고효율 분비능을 가지는 단백질 분비 인자 및 이를 포함하는 발현 벡터
KR20160045547A (ko) 2014-10-17 2016-04-27 에스케이텔레콤 주식회사 췌장암 진단용 조성물 및 이를 이용한 췌장암 진단방법
EP3546943A4 (de) 2016-11-24 2020-09-16 Huvet Bio, Inc. Zusammensetzung zur diagnose von krankheiten
WO2019022274A1 (ko) * 2017-07-28 2019-01-31 동아대학교 산학협력단 Pauf 단백질에 특이적으로 결합하는 항체 및 이의 용도
KR101856904B1 (ko) * 2017-07-28 2018-05-11 동아대학교 산학협력단 Pauf 단백질에 특이적으로 결합하는 항체 및 이의 용도
KR102111699B1 (ko) 2017-09-05 2020-05-15 (주)온코태그디아그노스틱 메티오닐-티알엔에이 합성효소를 이용한 췌장암 진단 방법 및 이를 이용한 췌장암 진단 키트
KR102536314B1 (ko) 2018-05-23 2023-05-25 주식회사 휴벳바이오 질환의 진단용 조성물

Family Cites Families (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4908773A (en) 1987-04-06 1990-03-13 Genex Corporation Computer designed stabilized proteins and method for producing same
US4962048A (en) * 1987-02-19 1990-10-09 Scripps Clinic & Research Foundation Monoclonal antibodies to human pancreatic cancer
US5143854A (en) 1989-06-07 1992-09-01 Affymax Technologies N.V. Large scale photolithographic solid phase synthesis of polypeptides and receptor binding screening thereof
US5399346A (en) 1989-06-14 1995-03-21 The United States Of America As Represented By The Department Of Health And Human Services Gene therapy
DK0562025T3 (da) 1990-12-06 2001-06-18 Affymetrix Inc Forbindelser og deres anvendelse i en binær syntesestrategi
US5331573A (en) 1990-12-14 1994-07-19 Balaji Vitukudi N Method of design of compounds that mimic conformational features of selected peptides
US5884230A (en) 1993-04-28 1999-03-16 Immunex Corporation Method and system for protein modeling
US5705335A (en) 1993-11-26 1998-01-06 Hendry; Lawrence B. Design of drugs involving receptor-ligand-DNA interactions
US5873052A (en) 1996-11-06 1999-02-16 The Perkin-Elmer Corporation Alignment-based similarity scoring methods for quantifying the differences between related biopolymer sequences
AU6762498A (en) * 1997-03-19 1998-10-12 Zymogenetics Inc. Secreted salivary zsig32 polypeptides
US6365369B1 (en) * 1998-04-01 2002-04-02 Human Genome Sciences, Inc. Prostate specific secreted protein
JP2002522018A (ja) * 1998-07-24 2002-07-23 財団法人相模中央化学研究所 疎水性ドメインを有するヒト蛋白質およびそれをコードするｄｎａ
KR20030000010A (ko) * 1998-09-01 2003-01-03 제넨테크, 인크. 추가적인 ｐｒｏ 폴리펩티드 및 그의 서열
JP2003518361A (ja) * 1998-09-01 2003-06-10 ジェネンテック・インコーポレーテッド 更なるｐｒｏポリペプチドとその配列
NZ510464A (en) * 1998-09-01 2004-05-28 Genentech Inc Further pro polypeptides and sequences thereof
WO2003106497A1 (en) * 2002-06-14 2003-12-24 Immunomedics, Inc. Monoclonal antibody pam4 and its use for diagnosis and therapy of pancreatic cancer
WO2004016637A1 (en) * 2002-08-14 2004-02-26 Lg Life Sciences Ltd. Gene families associated with liver cancer
WO2004050860A2 (en) * 2002-12-04 2004-06-17 Diadexus, Inc. Compositions, splice variants and methods relating to colon specific genes and proteins
EP1526381A1 (de) * 2003-10-21 2005-04-27 Medplant Genetics S.L. Verfahren zur in vitro Diagnose und in vitro Prognose von Pankreaskarzinom und für die Entwicklung von Arzneimittel gegen Pankreaskarzinom
WO2005113812A2 (en) * 2004-04-23 2005-12-01 Invitrogen Corporation Collections of matched biological reagents and methods for identifying matched reagents
US7820382B2 (en) * 2004-08-03 2010-10-26 Bauer A Robert Method for the early detection of breast cancer, lung cancer, pancreatic cancer and colon polyps, growths and cancers as well as other gastrointestinal disease conditions and the preoperative and postoperative monitoring of transplanted organs from the donor and in the recipient and their associated conditions related and unrelated to the organ transplantation

Also Published As

Publication number Publication date
RU2009100911A (ru) 2010-07-20
AU2007259576A1 (en) 2007-12-21
MX2008016146A (es) 2009-01-15
KR100954322B1 (ko) 2010-04-21
EP2024500A1 (de) 2009-02-18
CN101495634B (zh) 2013-05-29
EP2024500A4 (de) 2009-12-09
JP2009539400A (ja) 2009-11-19
MY150691A (en) 2014-02-28
RU2432399C2 (ru) 2011-10-27
ES2381766T3 (es) 2012-05-31
US20090188000A1 (en) 2009-07-23
CA2655213A1 (en) 2007-12-21
NO20090174L (no) 2009-01-12
NZ573102A (en) 2011-10-28
EP2024500B1 (de) 2012-02-01
KR20070119250A (ko) 2007-12-20
CN101495634A (zh) 2009-07-29
US20130059751A1 (en) 2013-03-07
WO2007145466A1 (en) 2007-12-21
JP5388844B2 (ja) 2014-01-15
ZA200900224B (en) 2009-12-30
BRPI0712830A2 (pt) 2012-07-24

Similar Documents

Publication Publication Date Title
ZA200900224B (en) Gene Family (LBFL313) associated with pancreatic cancer
WO2008008430A3 (en) Micro-rna-based methods and compositions for the diagnosis and treatment of colon cancer-related diseases
SI1802625T1 (sl) Disubstituirani pirazolobenzodiazepini, koristni kot inhibitorji za cdk2 in angiogenezo ter za zdravljenje prsnega raka, raka kolona, pljuäśnega rakain raka prostate
WO2008104543A3 (en) Method for predicting the occurrence of metastasis in breast cancer patients
WO2011087845A3 (en) Metabolomic profiling of prostate cancer
AU327035S (en) Shirt for sports
IL206079A0 (en) Microrna expression profiling and targeting in peripheral blood in lung cancer
CY1120123T1 (el) Μονοκλωνικα αντισωματα κατα της gt468 για τη θεραπεια του καρκινου
MX2010008817A (es) Tratamiento de cancer de prostata en etapa metastatica con degarelix.
EP2175879A4 (de) Behandlung von erkrankungen im zusammenhang mit prion-protein
WO2007134210A3 (en) Methods and compositions for the diagnosis and treatment of cancer
WO2008097466A3 (en) Metastasis specific splice variants of mena and uses thereof in diagnosis, prognosis and treatment of tumors
WO2008002672A3 (en) Targets for use in diagnosis, prognosis and therapy of cancer
WO2009026128A3 (en) Gene expression markers of recurrence risk in cancer patients after chemotherapy
CA119816S (en) Manikin chest shield
IL197727A0 (en) Combination treatment of cd38-expressing tumors
WO2005116259A3 (en) Use of gene expression profiling to predict survival in cancer patient
DK2179035T3 (da) Modificeret bakteriofag omfattende et alfa/beta-sasp-(small acid-soluble spore protein)-gen
CR20110479A (es) Combinaciones farmaceuticas que comprenden rdea 119/bay 869766 para el tratamiento de canceres especificos
BRPI0809079A2 (pt) tratamento de câncer com um combinado de il-18 humana e anticorpo anti-cd20
BRPI0715544A2 (pt) Anticorpos que modificam doença cancerosas.
WO2006133361A3 (en) Use of gene expression profiling to predict survival in cancer patient
WO2007112350A3 (en) Method of assessing the metastatic status of a primary tumor
SI1858929T1 (sl) Diagnoza raka prostate
MX2010001571A (es) Marcador predictivo para tratamiento con el inhibidor del receptor del factor de crecimiento epidermico.